Following a closed meeting of the Ciba Foundation on cocaine, it was decided to present some of the material discussed there to a wider audience. This provided the occasion for the first combined meeting of the Foundation with the Royal Society of Medicine.
Professor David Musto (Yale University School of Medicine, USA) reviewed the history of cocaine, particularly the American experience. There have been two cocaine epidemics which show many similarities, with initial enthusiastic acceptance of cocaine followed by intense public rejection, and a move from tolerance to intolerance. A major difference is that severe laws Were in place at the beginning of the second epidemic whereas they were enacted only as the first declined. In the late 19th century cocaine was advocated as a general 'tonic', with stimulant and therapeutic properties and without adverse effects. In Britain, it was restricted, but the image of cocaine changed only gradually in the USA, and laws regulating it were not passed until the early 1900s, with the first national law in 1914. Illicit sales of cocaine then rose, but its use gradually disappeared and was no longer a serious problem by the 1930s-only to reappear in the USA in the late 1960s, when it was again seen as a tonic, and experts commonly took a lenient attitude. However, when crack, a smokable, low cost form of cocaine, appeared about 1985 the public became alarmed, and anti-cocaine laws were strengthened.
The drug problem is commonly thought to be a serious contemporary problem, but past history is relevant. Both the European and American experiences are worthwhile fields for investigation.
In introducing the subject of pharmacotherapy, Dr Herbert Kleber (Office of National Drug Control Policy, USA) described the sequence of events and phases through which the cocaine user goes. The onset of action is rapid, with euphoria and good short-term effects, followed by their rapid reversal. More cocaine is taken -but in larger amounts to achieve the same effects. The usual pattern is binge use, with the cycle repeated over several hours or days, followed by a pause before there is again a craving for cocaine. The individual may become addicted, with neurological changes persisting in the brain for a significant period. Why many casual users do not become addicted is unclear. Psychiatric vulnerability, increased access to cocaine, and some routes ofadministration may predispose towards addiction. The average cocaine addict comes to treatment sooner than a heroin addict because he gets into trouble quicker because ofthe pattern ofuse.
Treatment should be individualized, but too often depends upon the centre to which the addict goes. The heterogeneity of the addict population adds to the difficulty of determining which treatments work. A variety of pharmacological approaches may be taken, but always in a psychological or behavioural context. The success rate is highest in individuals with skills and lowest in the classic crack addicts without social or vocational skills and little hope.
There are numerous clinical reports of success with drugs reducing the craving, increasing the abstinence period, etc, but the few controlled trials are contradictory. The tricyclic antidepressant, desipramine, seems efficacious in some trials, but is slow acting. Amantadine and bromocriptine have quicker effects, and neurotransmitter precursors show promise. Buprenorphine, an agonist-antagonist, has been shown to decrease cocaine use. Other drugs, for example, serotonin reuptake blockers and neuroleptics, show no or equivocal efficacy.
Professor Marian Fischman (Johns Hopkins University School of Medicine, USA) described carefully controlled laboratory studies of cocaine selfadministration in humans to evaluate the behavioural and physiological effects of cocaine and drugs used to control cocaine use. Rates of cocaine absorption, onset and fall-off of physiological and subjective effects vary according to the route of administration, being very rapid with inhaled cocaine so the free base, crack, is particularly dangerous. A single dose of cocaine gives dose-related rises in many physiological parameters, major subjective effects occurring at doses having small physiological effects. The short duration of action means that repeater! higher doses are taken before the physiological effects have returned to normal, so they become cumulative. Some of the toxicity may be due to interaction with the other drugs usually also taken. It is important to study patterns of cocaine taking and its effects in real life.
Professor Fischman discussed possible performance and learning deficits, and the overwhelming preoccupation of cocaine users with drug seeking and drug taking.
Studies with desipramine to determine whether the drug would shift drug-taking behaviour and alter the cardiovascular or subjective effects reduced the craving for cocaine, but the subjects took as much as previously. Desipramine seems subtly to change the profile of cocaine, slightly reducing its positive effects. This may enable users to consider previously unacceptable alternative reinforcers.
In discussion, the problems of the treatment of multiple drug abuse were stressed and the particular risks to which these subjects are exposed. There are no good data; studies in this group are difficult. With certain kinds of psychiatric history there may be a place for drugs not generally useful, eg lithium, methylphenidate. The importance of individual tailoring of treatment was again stressed.
Another topic which aroused considerable interest was the selective loss of public memory, with some events, eg alcohol prohibition, always remembered but others forgotten. Americans tend to go to the two idealistic extremes -all drugs are good, all drugs are bad -and there may have to be a selective loss of public memory and history as attitudes change.
Dr William Woolverton (University ofChicago, USA) complemented the human studies by describing cocaine self-administration studies in animals, measuring behaviour in response to agonists and antagonists to determine which of the neuronal actions of cocaine playa primary role in the reinforcing effect of cocaine.
Compounds with actions specific for the neurotransmitter effects were tested in agonist self-administration studies. Dopamine reuptake blockade seems to be an important mechanism in the stimulation of D2 receptors, with a primary role in the reinforcing effect of cocaine, whereas serotonin and noradrenergic reuptake blockade are not. Studies with antagonists strongly suggest that D2 antagonists (eg neuroleptics) can block, at least partially, some reinforcing effects of cocaine (again suggesting a role of D2 receptors). Dl antagonists showed interesting effects, suggesting a role for Dl receptors in the reinforcing effects of cocaine and that their development may lead to clinically useful compounds. Cocaine-maintained behaviour is not, however, exclusively determined by dopamine reuptake blockade and subsequent stimulation of Dl and D2 dopamine receptors, but is the result of interaction between the organism, the drug and the environment.
Experiments more nearly mimicking the human situation (where self-administration is rarely the only available behaviour), giving animals the choice between cocaine and another reinforcer, indicate that increasing the value of the reinforcer is an important way to reduce cocaine self-administration.
Dr Don Des Jarlais (Beth Israel Medical Center, USA) reported that cocaine users are at high risk of HIV transmission, with HIV infection and AIDS rapidly becoming the most common fatal complication of cocaine use. Equipment sharing makes injection procedures hazardous. In South America 30-50% of injecting drug users are sero-positive. Prevention programmes should be directed at preventing further transmission to sexual partners, offspring and other drug users. The dynamics of heterosexual transmission is unknown, but in South-East Asia there has been a rapid rise in HIV transmission from injecting drug users to non-injecting heterosexuals. Unsafe heterosexual practices associated with non-injected cocaine, particularly crack, also pose a risk.
Traditionally, illicit drug use has been predominantly by males, but with crack cocaine the sex ratio is 50 : 50, perhaps because it is easier to smoke, and because of the destabilization offamily structure and other social behaviours. Ethnographic studies indicate the importance of 'sex for crack' types of exchange: casual sexual exchange for crack, prostitution for money for crack, and direct exchange of sex for crack, with particular implications for attempts to reduce disease transmission, including HIV, and for drug abuse treatment. Many women so engaged are psychologically vulnerable. This may increase their liability to dependence upon crack, which provides a temporary increase in self-esteem.
To reduce the spread of HIV associated with cocaine use, future research needs must include better treatment for cocaine dependency applicable to populations of cocaine users on a public health scale, not just to individuals. Intensive psychotherapy will not be affordable either in developed countries or for preventing large epidemics in developing countries. The specifics of injection behaviour of cocaine users and the relationships between sexual behaviour and cocaine use also need elucidation.
The problem of HIV transmission within prisons was raised in discussion. Punishment must not be confused with incarceration. The first cocaine epidemic burnt out without imprisoning many people. Getting drug users into a treatment setting is a way of reducing HIV transmission, which is not achieved by criminalizing them. Governmental attitudes to drug taking have to be changed, and the politicians persuaded that behavioural changes are necessary among drug users. The way to achieve this is to attack the social problems in society because social circumstances are usually a major factor in drug use. Ifmore rewarding alternative behaviours are available, drug use may be decreased. This is not a model to which politicians are particularly attracted.
The validity of Dr Woolverton's animal studies was questioned. He considers them a good predictor of human behaviour, which help us understand specific components of that behaviour, pointing us in the direction of the development of potentially useful therapeutic compounds.
Professor Reese Jones (University of California, USA) combined discussion of clinical pharmacology and integrated approaches to treatment. Cocaine gives a sense of well-being and 80-95% of users do not become dependent. He discussed whether cocaine addiction is different from other drug addictions and/or more difficult to treat. An individualized approach to treatment is needed because of the binge pattern of cocaine use and the frequent concurrent use of other drugs. He repeated earlier statements that inhalation may cause rapid, astronomical transient peak plasma levels, triggering toxicities which are reinforced when more cocaine is taken before the physiological parameters have returned to normal. In addition to the acute toxicities, there are chronic physiological and psychological toxicities that come with repeated dosing. Withdrawal phenomena are intense, episodic and interminable, particularly depression and sudden craving.
Professor Reese Jones again emphasized that it is easier to take the medical model of treatment, putting a lot of money into a new drug rather than into improving life in ghetto areas of cities. Prevention techniques have to be applied, with skills training, new activities, etc to the patient who makes no attempt to stop taking cocaine, who relapses or is treatment-resistant. Treatment outcome studies with cocaine are primitive and there is no consensus about an established alternative treatment for cocaine dependence. Lobotomy, acupuncture, ECT and a 12-step self-help programme have all been advocated.
Professor Neal Benowitz (San Francisco General Hospital Medical Center, USA) dealt in more detail with the major toxicities of cocaine. He tried to give a perspective of cocaine medical toxicity (touching only briefly on the psychological toxicities) and the pathophysiology, with an estimate of the intrinsic Journal of the Royal Society of Medicine Volume 84 December 1991 755 toxicity of cocaine compared with other drugs. Most deaths are associated with multiple drug use, with sniffed and intravenous cocaine. The oral route can lead to death, mainly in body packers or stuffers smuggling cocaine. The long list of documented medical toxicities includes cardiovascular, CNS and infectious complications, hyperthermia and reproductive problems, most ofthem reflecting the intense sympathomimetic effects of cocaine. They can occur early, after single use, or sometimes several hours later. The magnitude of some of the complications is not really known. He illustrated these toxicities and ways of dealing with them by case reports.
The obstetric and fetal toxicities are worrying. Pregnant cocaine users usually have other problems and poor antenatal care. The 'crack baby syndrome' (neonatal toxicity) is of even more concern. There may be persistent neurobehavioural problems in babies born to cocaine-addicted mothers.
In 1989, cocaine accounted for the highest number of emergency room visits for drug abuse in the USA, 50% of them involving other drugs. Cocaine is a major acute medical problem, with a great impact in terms of major complications and death, but cigarette smoking and alcohol remain greater societal problems. The perspective of wider drug abuse has to be kept in mind.
Cocaine research in the USA, current priorities and future prospects were reviewed by Professor Reese Jones. Cocaine is a young person's drug now because it has become cheap. The trend in cocaine use is downwards in all ethnic groups, probably because the perception of risk is changing. Emergency room admissions and deaths are also down, except in innercity ghetto areas.
Professor Reese Jones discussed the needs, targeted areas and types of future research which may provide answers to the many questions and also give support to the treatment approaches that some of us may feel are preferable.
Epidemiology can address who uses cocaine and how, through household surveys and similar exercises. New treatment methods include various medication development programmes, behavioural and relapse prevention research, and on-going basic research. Outcome evaluation measures are also important. Targeted areas for future research include cocaine in pregnancy, prevention of its use in youth, cocaine and AIDS, and the encouragement of a public health model rather than legalistic and supply and demand reduction techniques.
Other questions relate to why many people in prison have drug abuse problems, why most people never experiment with cocaine or other drugs despite easy access and, if they do, do not become addicted. If they become addicted, why do some stop on their own or with minimal intervention, whereas other addicts find it so difficult? Focusing on this whole range of questions, and addressing the genetics of drug preference and drug seeking may ultimately give some clues about how the brain functions.
In addressing the way forward, Professor Griffith Edwards (Institute of Psychiatry, London, UK) said that certain very clear indications had come out of the meeting. He took as his theme the rise and fall of drug misuse epidemics, illustrating this with examples of past drug epidemics. Through time, across space, the same phenomenon described for cocaine is seen for other drugs. When the tide of cocaine has gone, our attention should be directed to the general issue of why epidemic use of drugs rises and falls, in an attempt to understand the patterns and interactions of drug use.
All drugs are different, with different reinforcing habits and toxicities. Each epidemic will be different, and no one type oflegislation or treatment will serve to deal with them all. The rise of drug abuse is always linked to something else: good communications and easy travel, together with a more open society, changes in the social network, breakdown of traditional social behaviour and changes in structure between the sexes, ethnic and age groups, the economic situation, criminal organization, market prices, technology and street chemistry. These many interacting issues must be addressed as well as the important research. Case comparison across time is needed to formalize our understanding of what it is about conditions of social strain which invite the rise of epidemics. Science cannot be taken in isolation.
It was again stressed in discussion that many cocaine users now are young, with multiple problems, including criminality, anorexia, family problems and prostitution. There was strong support for the suggestion that the starting point in any investigation is to ask the addict what he or she believes is the priority problem in his or her life.
Helping the lab to help us
Keywords: trace evidence contamination; DNA profiling; fibre identification; drunk driving
The summer symposium, held in the Royal College of Surgeons, Edinburgh, was arranged by Professor A Busuttil. The main theme of the day was the value to be derived from recovered trace material and the pitfalls in interpreting its significance. Many of the jurisprudential and statistical points raised during discussion were echoes of those which occupied the minds of scientists and others attending the International Association of Forensic Science meeting in Adelaide last year (see, passim, papers by Starrs and Stoney in Journal ofthe Forensic Science Society 1991;31).
Mr Richard Prentice, an assistant chief constable of the Lothian and Borders Police and Mr Lester Knibb, of the force's forensic science laboratory, gave a sequential presentation on the police management of both major incidents and serious crime, putting particular emphasis on the need to preserve the locus, so permitting scenes of crime officers to make the best use of whatever evidence is to be found there. The working of the Home Office Large Major Enquiry System (Holmes) was described: statements from all witnesses are recorded on a computer database, subsequent interrogation of which allows correlation of textual material from these statements, for example sightings of a particular model or colour of car. Both speakers illustrated by videofilm clips the Without being the solution to drug abuse, pharmacotherapy perhaps provides a window of opportunity during which other non-pharmacological treatments and alternative reinforcers can be brought to bear upon a person's behaviour. We must not get drug research out of proportion, but do everything possible to facilitate social support -which is probably no more expensive than the technological approach, but harder to implement, to obtain funds and get political support. Drug research is politically acceptable. It is much more difficult for politicians to accept that social therapy is needed. The drug issue has been used in the USA as an instrument of politics and foreign policy for many years. It is salutary to remember that some earlier social problems have been dealt with by social engineering and changes without any contribution from the medical profession.
This was an interesting and informative meeting, stressing repeatedly the particular problems associated with cocaine, the binge pattern of use leading to a greater risk of HIV transmission, multiple drug taking and, above all, that the solution to the problem is not merely medical. Pharmacotherapy must always be given in the context of social therapy.
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benefits of persistence, thoroughness, efficient procedures and teamwork.
Mr Ian Hamilton (Forensic Biologist, Strathclyde Police) left his audience somewhat bemused as he described the relative merits of multilocus and single probe DNA work, illustrating these techniques by autoradiographs. The assertion by forensic scientists that juries will believe the technical results they obtain, but yet be influenced by the advocacy of one side or another is likely to be dented by the seemingly endless string of criminal appeals successful years after conviction. The 'forensic physician' cannot derive even wry satisfaction from such juridical problems, for clinical expertise in this field is too often based on assertion.
Chief Inspector Eric Jansen (Grampian Police) gave a graphic description of the enquiries pursued into the abduction of a 3-year-old girl, drawing attention yet again to the importance of painstaking scene examination. A disturbing moral of his account was the implied need to exercise some degree of surveillance over those convicted or strongly suspected of serious offences, lest they offend in a similar way in the future. May information properly be passed to the authorities in another area when someone in this category moves elsewhere?
Mr Ray Palmer (Police Forensic Science Laboratory, Dundee) reminded the police surgeons present how readily shoddy methods of collecting traces from body surfaces and from clothing negate potentially good evidence, and even allow the wrong conclusions to be drawn. As ever smaller particles 
